IP Verse

Eirgen Pharma competitive analysis

Latest publications and patents of Eirgen Pharma New

Explore the latest publications and patents granted to Eirgen Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Oct 1, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Eirgen Pharma

EP3650016
May 5, 2021Stabilized Modified Release Vitamin D Formulation And Method Of Administering SameGranted And Under Opposition
EP3332773
Oct 14, 2020Stabilized Modified Release Vitamin D Formulation And Method Of Administering SameGranted And Under Opposition
EP2968172
Oct 7, 2020Stabilized Modified Release Vitamin D Formulation And Method Of Administring SameGranted And Under Opposition

Latest patents of Eirgen Pharma opposed by its competitors

Explore Eirgen Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3650016
May 5, 2021Stabilized Modified Release Vitamin D Formulation And Method Of Administering Same1
EP3332773
Oct 14, 2020Stabilized Modified Release Vitamin D Formulation And Method Of Administering Same1
EP2968172
Oct 7, 2020Stabilized Modified Release Vitamin D Formulation And Method Of Administring Same1

Latest PTAB cases involving Eirgen Pharma

Discover the latest PTAB cases involving Eirgen Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Eirgen Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
EIRGEN PHARMA - 3 - - Non-Active
DSM NUTRITIONAL PRODUCTS45 - - - Highly Aggressive